A stock icon

Agilent Technologies
A

$137.32
1.73%

Market Cap: 40.1B

 

About: Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools, cross lab (consisting of consumables and services related to life science and applied tools), and diagnostics and genomics. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. and China representing the largest country concentrations.

Employees: 17,600

0
Funds holding %
of 6,702 funds
0
Analysts bullish %
of 21 analysts
0
News positive %
of 7 articles

Fund manager confidence

Based on 2024 Q1 SEC filings by fund managers ($100M+ AUM)

9% more repeat investments, than reductions

Existing positions increased: 369 | Existing positions reduced: 338

9% more call options, than puts

Call options by funds: $147M | Put options by funds: $135M

5% more capital invested

Capital invested by funds: $35.6B [Q4 2023] → $37.2B (+$1.64B) [Q1 2024]

1% more first-time investments, than exits

New positions opened: 89 | Existing positions closed: 88

0% more funds holding

Funds holding: 977 [Q4 2023] → 978 (+1) [Q1 2024]

9.32% less ownership

Funds ownership: 87.46% [Q4 2023] → 78.14% (-9.32%) [Q1 2024]

11% less funds holding in top 10

Funds holding in top 10: 18 [Q4 2023] → 16 (-2) [Q1 2024]

Research analyst outlook

21 Wall Street Analysts provided 1 year price forecasts over the past 6 months

Low target
$90
34%
downside
Avg. target
$138
1%
upside
High target
$163
19%
upside

21 analyst ratings

positive
33%
11 neutral
52%
negative
14%
Citigroup
Patrick Donnelly
9%upside
$150
Buy
Upgraded
10 Jul 2024
Evercore ISI Group
Ross Muken
5%downside
$130
In-Line
Maintained
2 Jul 2024
B of A Securities
Derik De Bruin
2%upside
$140
Neutral
Maintained
25 Jun 2024
Jefferies
Brandon Couillard
2%downside
$135
Hold
Downgraded
3 Jun 2024
Barclays
Luke Sergott
9%downside
$125
Underweight
Maintained
31 May 2024

Financial journalist opinion

Based on 7 articles about A published over the past 30 days